Company Filing History:
3 out of 245 
2 out of 656 
1 out of 832,843 Years Active: 2000-2012
Title: The Pioneering Innovations of Karin Hartog in HIV Research
Introduction
Karin Hartog is a prominent inventor based in Piedmont, California, known for her significant contributions in the field of virology and immunology. With a commendable portfolio of 6 patents, she has focused her research on the expression of HIV polypeptides and the production of virus-like particles (VLPs). Her innovative work aims to advance therapeutic methods for combating HIV, a critical issue in global health.
Latest Patents
Hartog's latest patented invention centers around the efficient expression of HIV polypeptides in various cell types, which include mammalian, insect, and plant cells. The synthetic expression cassettes she developed encode HIV Gag-containing polypeptides, facilitating applications such as DNA immunization, creation of packaging cell lines, and production of Env-, tat-, or Gag-containing proteins. Furthermore, this invention outlines methodologies for producing VLPs, which can serve as vehicles for antigen presentation and stimulation of immune responses in patients who receive them. This dual focus on expression and application highlights her innovative approach to addressing the complexities of HIV.
Career Highlights
Throughout her career, Hartog has worked with leading companies in the biotechnology sector, including Novartis Vaccines & Diagnostics and Chiron Corporation. These affiliations provided her with valuable experience and resources, allowing her to contribute effectively to significant advancements in vaccine and therapeutic development.
Collaborations
Karin's collaborative efforts in the scientific community have included working alongside esteemed colleagues such as Susan Barnett and Ying Lian. These partnerships have played a vital role in enhancing her research, facilitating knowledge sharing, and driving innovation in HIV research.
Conclusion
In conclusion, Karin Hartog's inventive work and dedication to HIV research are shaping the landscape of immunology and virology. Her patents not only reflect her commitment to scientific advancement but also hold promise for the future of HIV treatment. As she continues to innovate and collaborate, the potential for breakthroughs in medical science remains high, paving the way for improved health outcomes worldwide.